# Pharvaris N.V. (PHVS)

Source page: https://stoqly.net/companies/phvs

- **Ticker:** PHVS (Nasdaq)
- **Sector:** Health Care / Pharmaceutical Preparations
- **SEC CIK:** 0001830487
- **Latest annual report:** 20-F filed 2026-04-02 (https://www.sec.gov/Archives/edgar/data/1830487/000183048726000013/phvs-20251231.htm)
- **Data updated:** 2026-11-09

## Key figures

- **Last close:** $34.47 on 2026-11-09 (+0.23% on the day)
- **Market cap:** $2.0B
- **EPS, trailing 12 months:** −$3.35
- **Revenue (FY2025):** $7.4M
- **Revenue growth:** +24.5%
- **Operating margin:** −2,658.2%
- **Net margin:** −2,688.6%
- **Free cash flow:** −$155M
- **Free cash flow margin:** −2,100.0%
- **Return on equity:** −66.4%
- **Change in share count:** +9.5%
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $20.4M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/phvs/figures.csv

| US$ millions | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|
| Revenue | — | — | — | 0 | 0 | 0 | 6 | 7 |
| Operating income | -5 | -9 | -30 | -50 | -80 | -108 | -143 | -196 |
| Net income | -5 | -9 | -30 | -51 | -80 | -109 | -145 | -198 |
| Diluted EPS (US$) | -1.05 | -1.86 | -6.11 | -1.66 | -2.39 | -2.84 | -2.68 | -3.35 |
| Operating cash flow | -5 | -7 | -25 | -53 | -71 | -101 | -130 | -155 |
| Free cash flow | -5 | -7 | -25 | -53 | -71 | -101 | -131 | -155 |
| Cash | 6 | 23 | 121 | 237 | 173 | 432 | 292 | 343 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.